市場調查報告書

多重化驗的全球市場:未來預測

Global Multiplex Assay Market Forecast 2019-2027

出版商 Inkwood Research 商品編碼 917681
出版日期 內容資訊 英文 143 Pages
商品交期: 2-3個工作天內
價格
Back to Top
多重化驗的全球市場:未來預測 Global Multiplex Assay Market Forecast 2019-2027
出版日期: 2019年03月12日內容資訊: 英文 143 Pages
簡介

本報告提供全球多重化驗市場未來展望相關分析,技術的概要和市場基本結構,主要的促進、阻礙因素,市場整體及各類型、各產品、各技術、各用途、各終端用戶、各地區的市場趨勢預測 (今後9年份),主要企業簡介等調查彙整。

第1章 分析範圍

第2章 分析方法

第3章 摘要整理

第4章 市場動態

  • 市場範圍和定義
  • 推動市場要素
  • 阻礙市場要素
  • 市場機會
  • 市場課題

第5章 各種類的市場

  • 蛋白質為基礎的多重化驗
  • 核酸為基礎的多重化驗
  • 其他

第6章 各產品的市場

  • 試劑、消耗品
  • 檢查裝置、配件
  • 軟體、服務

第7章 各技術的市場

  • 多重蛋白質微陣列
  • 多重PCR (聚合酵素鏈鎖反應)
  • 其他

第8章 各用途的市場

  • 臨床診斷
  • 研究開發 (R&D)
  • 搭配診斷

第9章 各終端用戶的市場

  • 醫院
  • 臨床檢驗室
  • 研究機關
  • 製藥/生物科技企業

第10章 主要指標

  • 波特的五力分析
  • 主要的購買標準
  • 市場主要趨勢
  • 市場機會矩陣

第11章 各地區分析

  • 北美 (美國,加拿大)
  • 歐洲 (德國,法國,英國,義大利,西班牙等)
  • 亞太地區 (日本,中國,印度,韓國,澳洲等)
  • 其他的國家 (RoW:南美,中東、非洲)

第12章 競爭環境

  • 市場佔有率分析
  • 企業簡介
    • ABCAM PLC.
    • AGILENT TECHNOLOGIES, INC.
    • BECTON DICKINSON AND COMPANY
    • BIO-RAD LABORATORIES, INC.
    • BIO-TECHNE CORPORATION
    • ILLUMINA, INC
    • LUMINEX CORPORATION
    • MERCK MILIPORE
    • MESO SCALE DIAGNOSTICS, LLC
    • OLINK PROTEOMICS AB
    • QIAGEN N.V.
    • RANDOX LABORATORIES LTD.
    • SEEGENE INC.
    • SIEMENS HEALTHINEERS
    • THERMO FISHER SCIENTIFIC INC.
目錄
Product Code: 28500

KEY FINDINGS

The global multiplex assay market is predicted to register a CAGR of 7.46% during the estimated period, 2019-2027. The economic benefits associated with the multiplex assay, the surging research and development activities, coupled with government funding, are the major factors pushing the growth of the global multiplex assay market.

MARKET INSIGHTS

Multiplex PCR is the widely demanded multiplex assay technology, while reagents and consumables are the products used widely. The multiplex assays have huge potential in the research and development activities, with regard to the treatment of diseases like cancer. There are increasing government investments across the countries of the world in terms of healthcare, which results in an increased number of research centers and clinical laboratories. The multiplex assay panel aids the needs of pharmaceutical researchers, thereby impacting the market growth of the multiplex assay. Further, the advancements in the healthcare infrastructure in the emerging economies result in ample growth opportunities for the multiplex assay market. However, the lack of skilled professionals is estimated to hinder the growth of the market.

REGIONAL INSIGHTS

The global market of the multiplex assay is examined through the market regions of North America, Asia Pacific, Europe, and the Rest of the World. As of 2018, North America held the largest market share, followed by Europe. The market region of Asia Pacific is expected to be the fastest-growing region during the forecasted period. The primary factors attributed to this growth are the increasing patient numbers and the surging R&D activities in the pharmaceuticals domain.

COMPETITIVE INSIGHTS

The increasing research and development activities are resulting in growth opportunities for both, the players and the market. Some of the eminent players in the market are, Bio-Rad Laboratories, Inc., Becton, Dickinson and Company, Agilent Technologies, Inc., Illumina Inc., Abcam Plc., Bio-Techne Corporation, etc.

Our report offerings include:

  • Explore key findings of the overall market
  • Strategic breakdown of market dynamics (Drivers, Restraints, Opportunities, Challenges)
  • Market forecasts for a minimum of 9 years, along with 3 years of historical data for all segments, sub-segments, and regions
  • Market Segmentation cater to a thorough assessment of key segments with their market estimations
  • Geographical Analysis: Assessments of the mentioned regions and country-level segments with their market share
  • Key analytics: Porter's Five Forces Analysis, Vendor Landscape, Opportunity Matrix, Key Buying Criteria, etc.
  • Competitive landscape is the theoretical explanation of the key companies based on factors, market share, etc.
  • Company profiling: A detailed company overview, product/services offered, SCOT analysis, and recent strategic developments

Table of contents

1. RESEARCH SCOPE

  • 1.1. STUDY GOALS
  • 1.2. SCOPE OF THE MARKET STUDY
  • 1.3. WHO WILL FIND THIS REPORT USEFUL?
  • 1.4. STUDY AND FORECASTING YEARS

2. RESEARCH METHODOLOGY

  • 2.1. SOURCES OF DATA
    • 2.1.1. SECONDARY DATA
    • 2.1.2. PRIMARY DATA
  • 2.2. TOP-DOWN APPROACH
  • 2.3. BOTTOM-UP APPROACH
  • 2.4. DATA TRIANGULATION

3. EXECUTIVE SUMMARY

  • 3.1. MARKET SUMMARY
  • 3.2. KEY FINDINGS
    • 3.2.1. NUCLEIC ACID-BASED MULTIPLEX ASSAYS ARE THE FASTEST GROWING TYPE
    • 3.2.2. REAGENTS AND CONSUMABLES ARE THE WIDELY USED PRODUCTS
    • 3.2.3. MULTIPLEX PCR IS THE HIGHLY DEMANDED MULTIPLEX ASSAY TECHNOLOGY
    • 3.2.4. MULTIPLEX ASSAYS ARE HIGHLY ECONOMICAL

4. MARKET DYNAMICS

  • 4.1. MARKET SCOPE & DEFINITION
  • 4.2. MARKET DRIVERS
    • 4.2.1. GROWING R&D ACTIVITIES & GOVERNMENTAL FUNDING
    • 4.2.2. PREFERENCE OF MULTIPLEX ASSAYS OVER CONVENTIONAL ASSAYS
    • 4.2.3. INCREASED ADOPTION OF PERSONALIZED MEDICINES
  • 4.3. MARKET RESTRAINTS
    • 4.3.1. LACK OF SKILLED PROFESSIONALS
  • 4.4. MARKET OPPORTUNITIES
    • 4.4.1. GROWING OPPORTUNITIES IN THE EMERGING ECONOMIES
    • 4.4.2. IDENTIFICATION OF NOVEL BIOMARKERS
  • 4.5. MARKET CHALLENGES
    • 4.5.1. STRINGENT REGULATIONS

5. MARKET BY TYPE

  • 5.1. PROTEIN-BASED MULTIPLEX ASSAYS
  • 5.2. NUCLEIC ACID-BASED MULTIPLEX ASSAYS
  • 5.3. OTHER MULTIPLEX ASSAYS

6. MARKET BY PRODUCT

  • 6.1. REAGENTS AND CONSUMABLES
  • 6.2. INSTRUMENTS AND ACCESSORIES
  • 6.3. SOFTWARE AND SERVICES

7. MARKET BY TECHNOLOGY

  • 7.1. MULTIPLEX PROTEIN MICROARRAY
  • 7.2. MULTIPLEX PCR
  • 7.3. OTHER TECHNOLOGY

8. MARKET BY APPLICATION

  • 8.1. CLINICAL DIAGNOSTICS
  • 8.2. RESEARCH AND DEVELOPMENT
  • 8.3. COMPANION DIAGNOSTICS

9. MARKET BY END-USER

  • 9.1. HOSPITALS
  • 9.2. CLINICAL LABORATORIES
  • 9.3. RESEARCH INSTITUTES
  • 9.4. PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES

10. KEY ANALYTICS

  • 10.1. PORTER'S FIVE FORCES MODEL
    • 10.1.1. THREAT OF NEW ENTRANTS
    • 10.1.2. THREAT OF SUBSTITUTE PRODUCTS
    • 10.1.3. BARGAINING POWER OF BUYER
    • 10.1.4. BARGAINING POWER OF SUPPLIER
    • 10.1.5. INTENSITY OF COMPETITIVE RIVALRY
  • 10.2. KEY BUYING CRITERIA
  • 10.3. KEY TRENDS
  • 10.4. OPPORTUNITY MATRIX

11. GEOGRAPHICAL ANALYSIS

  • 11.1. NORTH AMERICA
    • 11.1.1. THE UNITED STATES
    • 11.1.2. CANADA
  • 11.2. EUROPE
    • 11.2.1. GERMANY
    • 11.2.2. FRANCE
    • 11.2.3. THE UNITED KINGDOM
    • 11.2.4. ITALY
    • 11.2.5. SPAIN
    • 11.2.6. REST OF EUROPE
  • 11.3. ASIA PACIFIC
    • 11.3.1. JAPAN
    • 11.3.2. CHINA
    • 11.3.3. INDIA
    • 11.3.4. SOUTH KOREA
    • 11.3.5. AUSTRALIA
    • 11.3.6. REST OF ASIA-PACIFIC
  • 11.4. REST OF WORLD
    • 11.4.1. LATIN AMERICA
    • 11.4.2. MIDDLE EAST AND AFRICA

12. COMPETITIVE LANDSCAPE

  • 12.1. MARKET SHARE ANALYSIS
  • 12.2. COMPANY PROFILES
    • 12.2.1. ABCAM PLC.
    • 12.2.2. AGILENT TECHNOLOGIES, INC.
    • 12.2.3. BECTON DICKINSON AND COMPANY
    • 12.2.4. BIO-RAD LABORATORIES, INC.
    • 12.2.5. BIO-TECHNE CORPORATION
    • 12.2.6. ILLUMINA, INC
    • 12.2.7. LUMINEX CORPORATION
    • 12.2.8. MERCK MILIPORE
    • 12.2.9. MESO SCALE DIAGNOSTICS, LLC
    • 12.2.10. OLINK PROTEOMICS AB
    • 12.2.11. QIAGEN N.V.
    • 12.2.12. RANDOX LABORATORIES LTD.
    • 12.2.13. SEEGENE INC.
    • 12.2.14. SIEMENS HEALTHINEERS
    • 12.2.15. THERMO FISHER SCIENTIFIC INC.

LIST OF TABLES

  • TABLE 1: GLOBAL MULTIPLEX ASSAY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 2: GLOBAL MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 3: GLOBAL PROTEIN-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 4: GLOBAL NUCLEIC ACID-BASED MULTIPLEX ASSAYS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 5: GLOBAL OTHER MULTIPLEX ASSAYS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 6: GLOBAL MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 7: GLOBAL REAGENTS AND CONSUMABLES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 8: GLOBAL INSTRUMENTS AND ACCESSORIES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 9: GLOBAL SOFTWARE AND SERVICES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 10: GLOBAL MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 11: GLOBAL MULTIPLEX PROTEIN MICROARRAY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 12: GLOBAL MULTIPLEX PCR MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 13: GLOBAL OTHER TECHNOLOGY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 14: GLOBAL MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 15: GLOBAL CLINICAL DIAGNOSTICS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 16: GLOBAL RESEARCH AND DEVELOPMENT MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 17: GLOBAL COMPANION DIAGNOSTICS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 19: GLOBAL HOSPITALS MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 20: GLOBAL CLINICAL LABORATORIES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 21: GLOBAL RESEARCH INSTITUTES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 22: GLOBAL PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 23: GLOBAL MULTIPLEX ASSAY MARKET, BY REGION, 2019-2027 ($ MILLION)
  • TABLE 24: NORTH AMERICA MULTIPLEX ASSAY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 25: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 26: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 27: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 28: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 29: THE UNITED STATES MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 30: CANADA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 31: CANADA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 32: CANADA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 33: CANADA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 34: CANADA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 35: EUROPE MULTIPLEX ASSAY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 36: GERMANY MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 37: GERMANY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 38: GERMANY MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 39: GERMANY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 40: GERMANY MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 41: FRANCE MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 42: FRANCE MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 43: FRANCE MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 44: FRANCE MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 45: FRANCE MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 46: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 47: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 48: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 49: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 50: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 51: ITALY MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 52: ITALY MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 53: ITALY MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 54: ITALY MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 55: ITALY MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 56: SPAIN MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 57: SPAIN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 58: SPAIN MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 59: SPAIN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 60: SPAIN MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 61: ASIA PACIFIC MULTIPLEX ASSAY MARKET, BY COUNTRY, 2019-2027 ($ MILLION)
  • TABLE 62: JAPAN MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 63: JAPAN MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 64: JAPAN MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 65: JAPAN MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 66: JAPAN MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 67: CHINA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 68: CHINA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 69: CHINA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 70: CHINA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 71: CHINA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 72: INDIA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 73: INDIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 74: INDIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 75: INDIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 76: INDIA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 77: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 78: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 79: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 80: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 81: SOUTH KOREA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 82: AUSTRALIA MULTIPLEX ASSAY MARKET, BY TYPE, 2019-2027 ($ MILLION)
  • TABLE 83: AUSTRALIA MULTIPLEX ASSAY MARKET, BY PRODUCT, 2019-2027 ($ MILLION)
  • TABLE 84: AUSTRALIA MULTIPLEX ASSAY MARKET, BY TECHNOLOGY, 2019-2027 ($ MILLION)
  • TABLE 85: AUSTRALIA MULTIPLEX ASSAY MARKET, BY APPLICATION, 2019-2027 ($ MILLION)
  • TABLE 86: AUSTRALIA MULTIPLEX ASSAY MARKET, BY END-USER, 2019-2027 ($ MILLION)
  • TABLE 87: REST OF WORLD MULTIPLEX ASSAY MARKET, BY REGION, 2019-2027 ($ MILLION)

LIST OF FIGURES

  • FIGURE 1: GLOBAL MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 2: GLOBAL MULTIPLEX ASSAY MARKET SHARE, BY TYPE, 2018 & 2027 (%)
  • FIGURE 3: GLOBAL MULTIPLEX ASSAY MARKET, BY PROTEIN-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
  • FIGURE 4: GLOBAL MULTIPLEX ASSAY MARKET, BY NUCLEIC ACID-BASED MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
  • FIGURE 5: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER MULTIPLEX ASSAYS, 2019-2027 ($ MILLION)
  • FIGURE 6: GLOBAL MULTIPLEX ASSAY MARKET SHARE, BY PRODUCT, 2018 & 2027 (%)
  • FIGURE 7: GLOBAL MULTIPLEX ASSAY MARKET, BY REAGENTS AND CONSUMABLES, 2019-2027 ($ MILLION)
  • FIGURE 8: GLOBAL MULTIPLEX ASSAY MARKET, BY INSTRUMENTS AND ACCESSORIES, 2019-2027 ($ MILLION)
  • FIGURE 9: GLOBAL MULTIPLEX ASSAY MARKET, BY SOFTWARE AND SERVICES, 2019-2027 ($ MILLION)
  • FIGURE 10: GLOBAL MULTIPLEX ASSAY MARKET SHARE, BY TECHNOLOGY, 2018 & 2027 (%)
  • FIGURE 11: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PROTEIN MICROARRAY, 2019-2027 ($ MILLION)
  • FIGURE 12: GLOBAL MULTIPLEX ASSAY MARKET, BY MULTIPLEX PCR, 2019-2027 ($ MILLION)
  • FIGURE 13: ADVANTAGES OF IMMUNOHISTOCHEMISTRY (IHC)
  • FIGURE 14: GLOBAL MULTIPLEX ASSAY MARKET, BY OTHER TECHNOLOGY, 2019-2027 ($ MILLION)
  • FIGURE 15: GLOBAL MULTIPLEX ASSAY MARKET SHARE, BY APPLICATION, 2018 & 2027 (%)
  • FIGURE 16: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL DIAGNOSTICS, 2019-2027 ($ MILLION)
  • FIGURE 17: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH AND DEVELOPMENT, 2019-2027 ($ MILLION)
  • FIGURE 18: GLOBAL MULTIPLEX ASSAY MARKET, BY COMPANION DIAGNOSTICS, 2019-2027 ($ MILLION)
  • FIGURE 19: GLOBAL MULTIPLEX ASSAY MARKET SHARE, BY END-USER, 2018 & 2027 (%)
  • FIGURE 20: GLOBAL MULTIPLEX ASSAY MARKET, BY HOSPITALS, 2019-2027 ($ MILLION)
  • FIGURE 21: GLOBAL MULTIPLEX ASSAY MARKET, BY CLINICAL LABORATORIES, 2019-2027 ($ MILLION)
  • FIGURE 22: GLOBAL MULTIPLEX ASSAY MARKET, BY RESEARCH INSTITUTES, 2019-2027 ($ MILLION)
  • FIGURE 23: GLOBAL MULTIPLEX ASSAY MARKET, BY PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, 2019-2027 ($ MILLION)
  • FIGURE 24: PORTER'S FIVE FORCE MODEL
  • FIGURE 25: KEY BUYING CRITERIA
  • FIGURE 26: R&D SPENDING IN BIOPHARMACEUTICAL INDUSTRY GLOBALLY ($ BILLION)
  • FIGURE 27: NEWLY REGISTERED CLINICAL TRIAL STUDY, 2016-2018
  • FIGURE 28: GLOBAL MULTIPLEX ASSAY MARKET, REGIONAL OUTLOOK, 2018 & 2027 (%)
  • FIGURE 29: THE UNITED STATES MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 30: CANADA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 31: GERMANY MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 32: FRANCE MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 33: THE UNITED KINGDOM MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 34: ITALY MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 35: SPAIN MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 36: REST OF EUROPE MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 37: JAPAN MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 38: CHINA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 39: INDIA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 40: SOUTH KOREA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 41: AUSTRALIA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 42: REST OF ASIA-PACIFIC MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 43: LATIN AMERICA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 44: MIDDLE EAST AND AFRICA MULTIPLEX ASSAY MARKET, 2019-2027 ($ MILLION)
  • FIGURE 45: MULTIPLEX ASSAY COMPANY MARKET SHARE ANALYSIS, 2018 (%)
Back to Top